Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Capital Expenditures (2021 - 2023)

Historic Capital Expenditures for P3 Health Partners (PIII) over the last 3 years, with Q4 2023 value amounting to -$212000.0.

  • P3 Health Partners' Capital Expenditures fell 32400.0% to -$212000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$212000.0, marking a year-over-year decrease of 11065.86%. This contributed to the annual value of $1.8 million for FY2023, which is 1818.18% down from last year.
  • According to the latest figures from Q4 2023, P3 Health Partners' Capital Expenditures is -$212000.0, which was down 32400.0% from $387000.0 recorded in Q3 2023.
  • In the past 5 years, P3 Health Partners' Capital Expenditures ranged from a high of $1.2 million in Q2 2021 and a low of -$212000.0 during Q4 2023
  • In the last 3 years, P3 Health Partners' Capital Expenditures had a median value of $590088.5 in 2021 and averaged $612500.0.
  • The largest annual percentage gain for P3 Health Partners' Capital Expenditures in the last 5 years was 12671.76% (2023), contrasted with its biggest fall of 32400.0% (2023).
  • Over the past 3 years, P3 Health Partners' Capital Expenditures (Quarter) stood at $299870.0 in 2021, then plummeted by 116.67% to -$50000.0 in 2022, then crashed by 324.0% to -$212000.0 in 2023.
  • Its last three reported values are -$212000.0 in Q4 2023, $387000.0 for Q3 2023, and $1.2 million during Q2 2023.